Envoy Medical (COCH) Competitors $1.63 +0.07 (+4.49%) Closing price 01/30/2025 03:59 PM EasternExtended Trading$1.63 0.00 (-0.01%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends COCH vs. SRTS, TELA, ECOR, LNSR, FONR, MLSS, MGRM, GUTS, EDAP, and STIMShould you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include Sensus Healthcare (SRTS), TELA Bio (TELA), electroCore (ECOR), LENSAR (LNSR), FONAR (FONR), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), Fractyl Health (GUTS), Edap Tms (EDAP), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry. Envoy Medical vs. Sensus Healthcare TELA Bio electroCore LENSAR FONAR Milestone Scientific Monogram Orthopaedics Fractyl Health Edap Tms Neuronetics Envoy Medical (NASDAQ:COCH) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, community ranking, earnings, profitability and media sentiment. Do analysts recommend COCH or SRTS? Envoy Medical presently has a consensus price target of $8.00, indicating a potential upside of 390.77%. Sensus Healthcare has a consensus price target of $12.50, indicating a potential upside of 81.95%. Given Envoy Medical's higher possible upside, equities research analysts clearly believe Envoy Medical is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more volatility and risk, COCH or SRTS? Envoy Medical has a beta of 2.34, suggesting that its share price is 134% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Which has higher earnings and valuation, COCH or SRTS? Sensus Healthcare has higher revenue and earnings than Envoy Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$320K103.15-$29.91MN/AN/ASensus Healthcare$24.41M4.61$490K$0.5712.05 Does the MarketBeat Community prefer COCH or SRTS? Sensus Healthcare received 175 more outperform votes than Envoy Medical when rated by MarketBeat users. However, 100.00% of users gave Envoy Medical an outperform vote while only 68.42% of users gave Sensus Healthcare an outperform vote. CompanyUnderperformOutperformEnvoy MedicalOutperform Votes7100.00% Underperform VotesNo VotesSensus HealthcareOutperform Votes18268.42% Underperform Votes8431.58% Do institutionals and insiders hold more shares of COCH or SRTS? 8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 60.5% of Envoy Medical shares are held by insiders. Comparatively, 9.4% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media refer more to COCH or SRTS? In the previous week, Sensus Healthcare had 4 more articles in the media than Envoy Medical. MarketBeat recorded 5 mentions for Sensus Healthcare and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.87 beat Sensus Healthcare's score of 0.47 indicating that Envoy Medical is being referred to more favorably in the media. Company Overall Sentiment Envoy Medical Very Positive Sensus Healthcare Neutral Is COCH or SRTS more profitable? Sensus Healthcare has a net margin of 22.54% compared to Envoy Medical's net margin of -7,607.55%. Sensus Healthcare's return on equity of 17.99% beat Envoy Medical's return on equity.Company Net Margins Return on Equity Return on Assets Envoy Medical-7,607.55% N/A -262.28% Sensus Healthcare 22.54%17.99%16.26% SummarySensus Healthcare beats Envoy Medical on 10 of the 17 factors compared between the two stocks. Get Envoy Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCH vs. The Competition Export to ExcelMetricEnvoy MedicalSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.01M$10.23B$5.60B$9.14BDividend YieldN/A1.33%5.36%3.98%P/E RatioN/A19.9289.7717.66Price / Sales103.1528.461,211.9381.09Price / CashN/A23.5744.3437.71Price / Book-18.115.885.134.73Net Income-$29.91M$182.72M$118.85M$225.42M7 Day Performance1.25%0.46%1.46%0.75%1 Month Performance13.99%7.88%7.59%3.61%1 Year Performance40.53%2.06%26.64%21.42% Envoy Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCHEnvoy Medical3.1463 of 5 stars$1.63+4.5%$8.00+390.8%+25.4%$33.01M$320,000.000.0034Positive NewsGap DownSRTSSensus Healthcare3.5153 of 5 stars$6.56-2.5%$12.50+90.5%+107.6%$107.52M$24.41M11.5140Upcoming EarningsShort Interest ↑TELATELA Bio2.7323 of 5 stars$2.69+1.1%$9.25+243.9%-61.1%$105.96M$58.45M-1.59120ECORelectroCore2.9971 of 5 stars$15.90+1.3%$25.00+57.2%+106.2%$104.15M$16.03M-8.6950Short Interest ↓News CoverageLNSRLENSAR1.1636 of 5 stars$8.32-2.9%$8.00-3.8%+213.0%$96.60M$42.16M-5.70110Positive NewsFONRFONAR1.2596 of 5 stars$15.22-0.4%N/A-19.0%$96.34M$102.88M10.87480Short Interest ↑News CoverageMLSSMilestone Scientific0.6428 of 5 stars$1.18flat$1.25+5.9%+110.9%$91.91M$9.83M-16.8530Analyst ForecastGap DownMGRMMonogram Orthopaedics3.3048 of 5 stars$2.57+1.2%$4.00+55.6%-15.1%$88.18M$370,000.00-5.4728Short Interest ↓Positive NewsGUTSFractyl Health1.6135 of 5 stars$1.80-0.6%$22.00+1,122.2%N/A$86.58M$120,000.00-0.15102Short Interest ↑EDAPEdap Tms3.4541 of 5 stars$2.17-1.4%$19.00+775.6%-66.1%$80.52M$63.41M-3.34230Analyst ForecastShort Interest ↓News CoverageGap UpSTIMNeuronetics2.1731 of 5 stars$2.46+7.9%$4.67+89.7%-2.6%$74.66M$71.35M-2.00180Short Interest ↓High Trading Volume Related Companies and Tools Related Companies Sensus Healthcare Competitors TELA Bio Competitors electroCore Competitors LENSAR Competitors FONAR Competitors Milestone Scientific Competitors Monogram Orthopaedics Competitors Fractyl Health Competitors Edap Tms Competitors Neuronetics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:COCH) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
